| Literature DB >> 28331848 |
Rocco Cavaleri1, Siobhan M Schabrun1, Lucy S Chipchase1.
Abstract
The delivery of five stimuli to each cranial site is recommended during transcranial magnetic stimulation (TMS) mapping. However, this time-consuming practice restricts the use of TMS mapping beyond the research environment. While reducing the number of stimuli administered to each cranial site may improve efficiency and decrease physiological demand, doing so may also compromise the procedure's validity. Therefore, the aim of this study was to determine the minimum number of stimuli per cranial site required to obtain valid outcomes during TMS mapping. Map volume and centre of gravity (CoG) recordings obtained using five stimuli per cranial site were retrospectively compared to those obtained using one, two, three, and four stimuli per cranial site. For CoG longitude, one stimulus per cranial site produced valid recordings (ICC = 0.91, 95% CI 0.82 to 0.95). However, this outcome is rarely explored in isolation. As two stimuli per cranial site were required to obtain valid CoG latitude (ICC = 0.99, 95% CI 0.99 to 0.99) and map volume (ICC = 0.99, 95% CI 0.99 to 0.99) recordings, it is recommended that a minimum of two stimuli be delivered to each cranial site during TMS mapping in order to obtain valid outcomes.Entities:
Year: 2017 PMID: 28331848 PMCID: PMC5346381 DOI: 10.1155/2017/6328569
Source DB: PubMed Journal: Neurosci J ISSN: 2314-4262
Figure 1Method used to obtain blocks of varying numbers of stimuli per cranial site.
Map volume data (in mV) for varying numbers of stimuli per cranial site.
| Number of stimuli per cranial site | Median (IQR) | Mean difference with reference standard (95% CI) | ICC (95% CI) |
|---|---|---|---|
| One | 14.20 (8.18 to 24.07) | 2.85 (0.90 to 4.79) | 0.90 (0.62–0.96) |
| Two | 12.08 (6.83 to 18.30) | 0.11 (−0.38 to 0.60) | 0.99 (0.99–0.99) |
| Three | 14.07 (7.09 to 20.34) | 0.73 (0.11 to 1.36) | 0.99 (0.96–0.99) |
| Four | 12.92 (6.89 to 19.70) | 0.37 (0.08 to 0.67) | 0.99 (0.99–0.99) |
| Five | 12.52 (6.61 to 18.43) | NA | 1.00 (NA) |
Key: IQR = interquartile range, ICC = intraclass correlation coefficient with five stimuli per cranial site (the “true” value), CI = confidence interval, and NA = not applicable.
Figure 2Mean TMS maps for varying numbers of stimuli per cranial site. The black cross (x) highlights the map centre of gravity.
CoG latitude (in cm away from vertex) for varying numbers of stimuli per cranial site.
| Number of stimuli per cranial site | Mean (SD) | Mean difference with reference standard (95% CI) | ICC (95% CI) |
|---|---|---|---|
| One | 3.40 (0.85) | 0.10 (−0.01 to 0.20) | 0.97 (0.92 to 0.99) |
| Two | 3.31 (0.79) | 0.01 (−0.02 to 0.04) | 0.99 (0.99 to 0.99) |
| Three | 3.32 (0.81) | 0.02 (−0.02 to 0.06) | 0.99 (0.99 to 0.99) |
| Four | 3.32 (0.81) | 0.02 (−0.02 to 0.05) | 0.99 (0.99 to 0.99) |
| Five | 3.30 (0.80) | NA | 1.00 (NA) |
Key: SD = standard deviation, ICC = intraclass correlation coefficient with five stimuli per cranial site (the “true” value), CI = confidence interval, and NA = not applicable.
CoG longitude (in cm away from vertex) for varying numbers of stimuli per cranial site.
| Number of stimuli per cranial site | Mean (SD) | Mean difference with reference standard (95% CI) | ICC (95% CI) |
|---|---|---|---|
| One | 2.70 (1.04) | 0.06 (−0.02 to 0.14) | 0.99 (0.97 to 0.99) |
| Two | 2.64 (1.01) | −0.01 (−0.04 to 0.02) | 0.99 (0.99 to 0.99) |
| Three | 2.67 (1.01) | 0.02 (−0.01 to 0.06) | 0.99 (0.99 to 0.99) |
| Four | 2.66 (1.01) | 0.02 (−0.07 to 0.11) | 0.99 (0.97 to 0.99) |
| Five | 2.64 (1.03) | NA | 1.00 (NA) |
Key: SD = standard deviation, ICC = intraclass correlation coefficient with five stimuli per cranial site (the “true” value), CI = confidence interval, and NA = not applicable.
| Controlled | |
|---|---|
|
| |
| Age of subjects | Y |
| Gender of subjects | Y |
| Handedness of subjects | Y |
| Subjects prescribed medication | Y |
| Use of CNS active drugs (e.g., anticonvulsants) | Y |
| Presence of neurological/psychiatric disorders | Y |
| Any medical conditions | Y |
| History of specific repetitive motor activity | Y |
|
| |
| Position and contact of EMG electrodes | Y |
| Amount of contraction of target muscles | Y |
| Prior motor activity of the muscle to be tested | Y |
| Relaxation of muscles other than those tested | N |
| Coil type (size and geometry) | Y |
| Coil orientation | Y |
| Direction of induced current in the brain | Y |
| Coil location and stability | Y |
| Type of stimulator used (e.g., brand) | Y |
| Stimulation intensity | Y |
| Pulse shape (monophasic or biphasic) | Y |
| Determination of optimal hotspot | Y |
| The time between MEP trials | Y |
| Time between days of testing | Y |
| Subject attention (level of arousal) during testing | N |
| Method for determining threshold (active/resting) | Y |
| Number of MEP measures made | Y |
| Method for determining MEP size during analysis | Y |
|
| |
|
| 24 |
Key: Y = yes, N = no, CNS = central nervous system, EMG = electromyography, and MEP = motor evoked potential.